Desmopressin Acetate
NDC Package 16714-015-01
Package Information
Desmopressin Acetate is desmopressin is used to control the amount of urine your kidneys make. Marketed by Northstar Rxllc, this product is identified by NDC 16714-015 and is authorized under FDA application ANDA091280.
Identification & Billing
Clinical Specifications
Regulatory & Marketing
Hierarchy Structure
- 16714 - Northstar Rxllc
- 16714-015 - Desmopressin Acetate
- 16714-015-01 - 1 VIAL in 1 CARTON / 10 mL in 1 VIAL
- 16714-015 - Desmopressin Acetate
The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.
* Please review the full disclaimer at the bottom of this page.
Billing & HCPCS Mapping
To facilitate insurance claims and reimbursement, this drug package is mapped to specific HCPCS administrative codes. This crosswalk aligns clinical data with the billing standards used in ASP (Average Sales Price), AWP, and OPPS payment systems. Use the cards below to identify the correct billable units for provider claims.
Note for Medical Coders: These mappings are synthesized from various CMS datasets including OPPS, PrEP, and DAC (Data Analysis and Coding) contractors. Always confirm unit conversions against the current quarter's pricing files before final submission.
* Please review the full disclaimer at the bottom of this page.
Frequently Asked Questions
What is the distribution configuration for this product package?
The code 16714-015-01 identifies a specific commercial package of 1 vial in 1 carton / 10 ml in 1 vial of Desmopressin Acetate, labeled by Northstar Rxllc. This is formulated for use and contains as the active substance.
Is this product currently listed with the FDA?
This product code is currently listed as inactive or excluded from the primary directory. It was introduced to the market by Northstar Rxllc on July 01, 2020. The current certification is valid through May 31, 2024.
What are the primary indications for this medication?
Desmopressin is used to control the amount of urine your kidneys make. Normally, the amount of urine you make is controlled by a certain substance in the body called vasopressin. In people who have "water diabetes" (diabetes insipidus) or certain kinds of head injury or brain surgery, the body does not make enough vasopressin. Desmopressin is a man-made form of vasopressin and is used to replace a low level of vasopressin. This medication helps to control increased thirst and too much urination due to these conditions, and helps prevent dehydration. Desmopressin products applied in the nose are no longer indicated to control nighttime bedwetting in children because of the increased risk of developing a serious side effect (a low level of sodium in the blood).
How is this Northstar Rxllc product billed for insurance claims?
For medical billing and reimbursement, this package follows the 11-digit CMS format: 16714001501. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.
11-Digit Code Conversion
Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:
Note: The zero is added to the Product segment to maintain the 5-4-2 structure.
